RT Journal Article
T1 Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?
A1 Rivero-Juarez, Antonio
A1 Frias, Mario
A1 Lopez-Lopez, Pedro
A1 de Los Angeles Risalde, María
A1 Brieva, Teresa
A1 Machuca, Isabel
A1 Camacho, Angela
A1 Martinez-Peinado, Antonio
A1 Gomez-Villamandos, Jose Carlos
A1 Rivero, Antonio
K1 HIV
K1 Hepatitis C
K1 Hepatitis E
K1 Reactivation
K1 Reinfection
AB Although hepatitis E virus (HEV) is regarded as a self-limiting infection and anti-HEV antibodies seem to protect against reinfection, its pathogenesis is not well established. We describe 2 cases of acute symptomatic HEV infection after hepatitis C therapy in patients carrying anti-HEV immunoglobulin G antibodies, raising 2 major questions: reactivation or reinfection?
PB OXFORD ACADEMIC
YR 2017
FD 2017-01-03
LK http://hdl.handle.net/10668/10766
UL http://hdl.handle.net/10668/10766
LA en
NO Rivero-Juarez A, Frias M, Lopez-Lopez P, de Los Angeles Risalde M, Brieva T, Machuca I, et al. Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection? Clin Infect Dis. 2017 Apr 1;64(7):964-966
DS RISalud
RD Apr 19, 2025